Fragile X syndrome results from a loss of the RNA-binding protein fragile X mental retardation protein (FMRP). How FMRP regulates neuronal development and function remains unclear. Here we show that FMRP-deficient immature neurons exhibit impaired dendritic maturation, altered expression of mitochondrial genes, fragmented mitochondria, impaired mitochondrial function, and increased oxidative stress. Enhancing mitochondrial fusion partially rescued dendritic abnormalities in FMRPdeficient immature neurons. We show that FMRP deficiency leads to reduced Htt mRNA and protein levels and that HTT mediates FMRP regulation of mitochondrial fusion and dendritic maturation. Mice with hippocampal Htt knockdown and Fmr1knockout mice showed similar behavioral deficits that could be rescued by treatment with a mitochondrial fusion compound. Our data unveil mitochondrial dysfunction as a contributor to the impaired dendritic maturation of FMRP-deficient neurons and suggest a role for interactions between FMRP and HTT in the pathogenesis of fragile X syndrome.
F ragile X syndrome (FXS) is the most common heritable cause of intellectual disability and the highest single-gene contributor to autism 1 . FXS patients exhibit extensive behavioral deficits including impaired executive functions, defective learning, heightened anxiety, and impaired social ability 1, 2 . FXS arises largely from mutations in the fragile X mental retardation (FMR1) gene resulting in deficiency of FMRP, a brain and neuron-enriched RNA-binding protein 3 . How FMRP deficiency impairs brain function remains unclear. Studies of postmortem adult human FXS brains have identified several neuropathological features including immature dendritic spines of neurons 4 . However, whether this deficit results from impaired development or altered plasticity during adulthood remains unclear. It has been shown that neurons differentiated from FXS patient-derived induced pluripotent stem cells (iPSCs) display impaired neurite extension 5 . Additionally, both forebrain neurons differentiated from FXS human embryonic stem cells 6, 7 and hippocampal neurons isolated from neonatal Fmr1-knockout (KO) mice 8, 9 exhibit deficits in synaptic plasticity and neurite extension. Furthermore, we have shown that FMRP-deficient adult hippocampal new neurons also exhibit impaired dendritic and spine maturation 9 . Therefore, FMRP seems to have important roles in neuronal maturation across neuronal types and developmental ages. However, despite the identification of many mRNAs regulated by FMRP 3, 10, 11 , how FMRP deficiency affects neuronal development remains unclear.
Neurons depend on mitochondria, which not only provide energy to power cellular function through oxidative phosphorylation, but also regulate cellular oxidation-reduction status, calcium levels, signal transduction, and apoptosis 12 . During embryonic development, mitochondria are important for neural progenitor proliferation 13 and neuronal survival 14 . Alterations in mitochondrial morphology and function directly impact morphological development of neurons 15 . In adult brains, decreased mitochondrial ATP production impairs dendritic maturation of adult-born hippocampal neurons 16 . A large number of neurodegenerative diseases have been associated with disruptions of mitochondrial function 17 . However, it remains unexplored whether mitochondrial dysfunction contributes to pathogenesis of FXS. A limited number of studies have shown metabolic changes in the brain of Fmr1-KO mice, including increased rate of glucose metabolism 18 , elevated metabolic and oxidative stress 19 , increased reactive oxygen species (ROS) production, and abnormal nitric oxide metabolism 20, 21 , as well as altered energy metabolism at the systemic level 22 . FMRP promotes protein translation of superoxide dismutase, a regulator of oxidative stress 23 . However, whether FMRP deficiency affects mitochondrial function and its implication for neuronal development remain unknown.
In the present study, we report that FMRP has a critical role in dendritic maturation of adult-born new neurons, neonatal hippocampal neurons, and human neurons developed in transplanted mouse brains. We discovered that FMRP-deficient immature neurons exhibited altered expression of mitochondrial genes, fragmented mitochondria, impaired mitochondrial function, and increased oxidative stress. Enhancing mitochondrial fusion by either a chemical activator or exogenous expression of mitochondrial fusion genes rescued both mitochondrial morphology and dendritic maturation Articles NATuRE NEuROsciENcE deficits of FMRP-deficient neurons. We discovered that FMRP deficient neurons had reduced HTT levels, and acute knockdown of HTT recapitulates both mitochondrial fusion and neuronal maturation deficits seen in Fmr1-KO neurons. We used guide RNAs to target modified CRISPR/Cas9 (dCas9-VP64-SAM) to selectively activate the endogenous Htt gene in neurons and show that increased Htt transcription rescued both mitochondrial fusion and dendritic maturation deficits of Fmr1-KO neurons. Finally, we show that mice with HTT knockdown in the hippocampus exhibited several behavioral deficits similar to Fmr1-mutant mice, and treatment with a mitochondrial fusion compound rescued behavioral deficits of both Fmr1-KO mice and mice with hippocampal knockdown of HTT. Our data demonstrate that mitochondrial dysfunction contributes to the impaired maturation of FMRP-deficient developing neurons and present a cross-talk between FMRP and HTT in pathogenesis of human diseases.
Results
Selective deletion of FMRP from immature neurons leads to impaired transition into mature neurons. We have shown that deletion of FMRP from NSCs in the adult dentate gyrus (DG) leads to reduced neurogenesis and cognitive functions, which can be rescued by restoring FMRP functions in adult NSCs either genetically or pharmacologically [24] [25] [26] [27] . However, the specific role of FMRP during maturation of adult-born neurons remains unexplored. Doublecortin (DCX) is a microtubule-associated protein required for neuronal migration and is exclusively expressed in neuronal precursor cells and immature neurons. In the adult DG, neuronal precursors begin to express DCX while actively dividing, and continue to express DCX for 2 to 3 weeks as they develop into mature neurons that express neuronal nuclear antigen (NeuN, gene product of Rbfox3) 28 . We generated tamoxifen (TAM)-inducible conditional FMRP knockout mice (cKO;Cre;tdT or cKO) and littermate controls (Ctrl;Cre;tdT or control) by crossing Dcx promoterdriven inducible Cre (Dcx-Cre ERT2 ) mice, Cre-dependent tdTomato (tdT) reporter mice, and heterozygote female loxP-flanked Fmr1 (Fmr1 loxP/+ ) mice ( Fig. 1a and Supplementary Fig. 1a,b ). We injected 6-week-old cKO and control mice with TAM and analyzed at 3, 7, 14, 28, or 56 days after injection, corresponding to key developmental stages of adult new neurons 28 (Fig. 1b) . At 3 days after the last TAM injection, most DCX + cells in the DG of both cKO and control mice were tdT + (Fig. 1e ) which persisted to at least day 56. FMRP expression was detected in the tdT + DCX + cells of the control mice but not the cKO mice ( Fig. 1d, Supplementary Fig. 2 ), indicating that TAM injection resulted in efficient Cre-mediated recombination in DCX + population. There is no detectable tdT expression in the DG of mice without Cre ( Supplementary Fig. 3 ). The expression of tdT was found in the proliferating cells (Ki67 + , Supplementary Fig. 1c ) and neuroblasts (TBR2 + , Supplementary Fig. 1d ) but not in radial glia-like NSCs (RGLs, NESTIN + GFAP + ) ( Supplementary Fig. 1e ), astrocytes (S100β + ), or mature neurons (NeuN + ) ( Supplementary  Fig. 1f ). Therefore, FMRP was specifically deleted in DCX + cells.
We quantified the number of tdT + cells in the subgranular zone (SGZ, Fig. 1c ) and the internal granular layer inner granule cell layer (IGL, Supplementary Fig. 4a ), where the cell bodies of immature neurons are typically located 24, 26 . The cKO mice did not show significant change in the number of tdT + new cells from day 3 to day 14 post TAM injection. There was no significant difference in the Ki67 + dividing population between genotypes at day 3 ( Supplementary  Fig. 4b ), suggesting that FMRP deletion did not affect proliferation and generation of DCX + neuroblasts. However, cKO mice had a significantly lower number of tdT + cells at day 28 and day 56 compared with that in control mice ( Fig. 1f ), without change in the overall volume of the DG ( Supplementary Fig. 4c ). Adult-born DG neurons switch from expressing DCX to expressing NeuN during maturation 28 ; therefore DCX and NeuN expression have been used to assess stages of new neuron development ( Fig. 1g ). We found that the number of DCX-only immature cells (DCX + NeuN − , Fig. 1h ) increased significantly in the SGZ of cKO mice at day 7 but exhibited no significant change after day 14, compared with the control mice ( Fig. 1k ). The number of immature neurons transitioning from immature to mature stage (DCX + NeuN + , Fig. 1i ) did not show significant differences between genotypes until day 56, when cKO mice exhibited significantly reduced DCX + NeuN + cells compared with controls ( Fig. 1l ). On the other hand, the number of NeuNonly mature neurons (DCX − NeuN + , Fig. 1j ) were substantially lower in the cKO compared with the control mice from day 7 to day 56, with statistically significant reductions at both day 7 and day 28 ( Fig. 1m ). These data suggest that selective deletion of FMRP from DCXexpressing immature neurons led to an initially transient increase of 
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immature neurons but significant reduction in the final stage of maturation, leading to reduced number of mature new neurons in the DG.
FMRP-deficient DCX immature neurons in the adult DG exhibit impaired maturation. Immature DG new neurons undergo morphological changes during maturation 28 . Our previous studies have shown that deletion of FMRP from NESTIN-expressing NSCs leads to reduced dendritic maturation of DG new neurons 9, 24 . However, it is unclear whether this deficit results from impaired NSC differentiation 26, 29 or defective neuronal maturation. We therefore injected retrovirus-expressing Cre driven by a Dcx promoter (retro-pDcx-Cre) together with retrovirus-expressing Cre-dependent GFP (retro-flip-GFP) into the DG of FMRP-cKO (Fmr1 loxP/y ) and FMRP-cON (Fmr1 loxP−Neo/y ) mice that express less than 10% FMRP in the absence of Cre 24 ( Fig. 2a-c ). Retroviruses transduce only dividing cells, but Cre is active only after the infected NSCs have differentiated into DCX + immature neurons. At 28 days after viral injection, GFP + neurons in cKO mice exhibited reduced FMRP expression, whereas the cON mice exhibited increased expression ( Supplementary Fig. 5 ). The DCX + newborn neurons in cKO mice showed significant reductions in dendritic complexity, total 
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dendritic length, number of branching points, and number of dendritic ends compared with GFP+ neurons in WT mice ( Fig. 2d-h ).
On the other hand, restoration of FMRP selectively in DCX + new neurons in the cON mice rescued dendritic morphology deficits ( Fig. 2e-h ). Therefore, FMRP expression in DCX + newborn neurons is crucial for dendritic maturation.
To assess the functional impact of FMRP deletion in immature neurons on synaptic transmission of DG newborn neurons, we injected retrovirus-expressing neuronal synapsin promoter-driven Cre and GFP into the DG of adult cKO mice. At 4 to 5 weeks after viral injection, we recorded evoked action potential (AP) and pharmacologically isolated spontaneous miniature excitatory postsynaptic currents (mEPSCs) of GFP + neurons (Fig. 2i,j) . We found no significant differences in the intrinsic properties, action potential firing, resting membrane potential (RMP), membrane capacitance, input resistance, and membrane time constant of GFP + newborn DG cells between cKO and control mice ( Supplementary Fig. 6a -g). Additionally, we found no significant difference in the amplitude (Fig. 2k ,l), rise time ( Supplementary Fig. 6h ) and time constant of decay ( Supplementary Fig. 6i ) of mEPSCs between GFP + cells from cKO and WT mice ( Fig. 2j ). However, the frequency of mEP-SCs recorded from GFP + DG cells in cKO mice was significantly decreased compared with those in WT mice ( Fig. 2m ,n). These results suggest that FMRP deficiency in immature neurons impairs their ability to receive excitatory transmission which may result from dendritic maturation deficits. Therefore, FMRP is essential for proper neuronal maturation.
FMRP-deficient developing neurons have altered expression of metabolic genes.
To investigate the molecular mechanism underlying FMRP-regulated maturation of newborn neurons, we crossed Fmr1-KO mice with Dcx-DsRed transgenic mice in which DCX + cells express DsRed 30 . We isolated DsRed + cells from the DG of 6-week-old Fmr1 −/y ;Dcx-DsRed and control Fmr1 +/y ;Dcx-DsRed littermates using fluorescence activated cell sorting (FACS; Fig. 3a ,b). Consistent with our previous observation 30 , FACS-isolated DsRed + cells expressed high levels of Dcx and DsRed mRNA, but not Nestin or Rbfox3 mRNA ( Supplementary Fig. 7 ). Transcriptomic analysis of DsRed + cells of two pairs of KO and WT samples yielded 519 differentially expressed genes (false discovery rate (FDR)-adjusted P < 0.05) ( Supplementary Table 1a ,b). These 519 genes were enriched in pathways involved in metabolism, organelle organization, synaptic transmission, wounding, intracellular transport and cell development ( Fig. 3c,d , Supplementary Table 2 ). Among them, the metabolic pathways containing 146 (21.9%) differentially expressed genes ranked second among all pathways ( Fig. 3d and Supplementary Table 3a ).
Neuronal metabolism is highly dependent on mitochondrial functions 12 . We confirmed that several differentially expressed genes involved in mitochondrial functions had altered levels in hippocampal neurons isolated from Fmr1-KO mice ( Supplementary  Fig 8) . The impact of FMRP deficiency on mitochondria has not been determined. We therefore assessed the levels of nitrotyrosine, a marker for oxidative stress. We found that the tdT + new adult DG neurons in cKO;Cre;tdT mice exhibited increased nitrotyrosine level compared with those in the control mice ( Fig. 3e ,f). To visualize mitochondria in DG newborn neurons, we injected a retrovirus carrying mitochondria-targeted DsRed (Retro-pCAG-mitoDsRed) 16 into the DG of 6-week-old Fmr1-KO and WT mice and assessed the mitochondrial morphology at 14 days after viral injection (Fig. 3g ). The mitochondria in the proximal dendrites of DCX + immature neurons of the KO mice were significantly shorter (reduced aspect ratio) compared with those in WT mice ( Fig. 3h ,i), suggesting that the mitochondria were more fragmented in FMRP-deficient immature neurons. Therefore, deletion of FMRP from DCX-expressing immature neurons significantly impacts metabolic processes, which may result from mitochondrial dysfunction.
FMRP-deficient DCX + immature neurons have impaired mitochondrial fusion.
To determine whether FMRP deficiency affects mitochondrial morphology in developing neurons and identify the developmental time points of this effect, we transfected primary hippocampal neurons 8, 9 with vectors expressing mitochondrialtargeting GFP (mitoGFP) and an shRNA against Fmr1 (shFmr1) 9 at 4, 6, and 9 days after plating (DIV) and analyzed on DIV 15 ( Supplementary Fig. 9 ). We found that shFmr1-transfected neurons had more fragmented mitochondria compared with controls (shNC) at all time points, with neurons transfected at DIV 4 exhibiting the most profound changes, suggesting that the impact of FMRP knockdown on mitochondrial shape occurred early during neuronal maturation. We therefore focused on the early time point (DIV 4) for the remaining studies.
Next, we assessed mitochondria in neurons isolated from Fmr1-KO mice transfected with mitoDsRed and cytosolic GFP. All mitoDsRed + cells were DCX + ( Supplementary Fig. 10a ). We found no significant difference in either mitochondrial density or coverage area between KO and WT neurons ( Supplementary Fig. 10b ,c). However, mitochondria in Fmr1-KO neurons exhibited significantly reduced aspect ratio compared with those in WT neurons ( Fig. 4a,b ), similar to our observation in the adult DG ( Fig. 3 ). We then assessed the function of mitochondria by examining the mitochondrial membrane potential (MMP), and KO neurons exhibited significantly reduced MMP compared with WT neurons (Fig. 4c,d) . Recently, discrepancies between findings in mouse and human have raised extensive discussion 1 . To evaluate the development of human FXS neurons, we transplanted neural progenitor cells (NPCs) differentiated from control-derived and FXS-patient-derived iPSCs 5, 31 into the cortex of immune-deficient mouse brains and analyzed at 4 months post-transplantation. We found that FXS human neurons developed in transplanted mouse brains also exhibited impaired dendritic maturation and increased oxidative stress ( Supplementary Fig. 11 ). Thus, our data suggest that FMRP deficiency impairs mitochondrial and metabolic functions in both mouse and human neurons.
Enhancing mitochondrial fusion rescues FMRP-deficient immature neurons. Mitochondria undergo frequent morphological changes through fission and fusion 17 . Because the overall area of mitochondria coverage did not change ( Supplementary Fig. 10 ), the reduced aspect ratio in FMRP-deficient neurons might be a result of either increased fission or reduced fusion. We therefore used a photoswitching assay to assess mitochondrial fission and fusion dynamics ( Fig. 4e-g) . We transfected Fmr1-KO and WT neurons with mito-mEos3.2. mEOS3.2 is a green fluorescent protein but can be converted to a red fluorescent protein with 405 nm light. Nearly all mitochondria in mito-mEos3.2-transfected neurons were green ( Fig. 4e) We then selectively converted a fraction of them to red and used live imaging to monitor mitochondrial dynamics in a fragment of dendrite. Any green mitochondria that was not originally photoswitched but turned red must either be a part of the original mitochondria or it must have fused with the photo switched mitochondria. We compared the area of photoswitched mitochondria between time T = 0 and time T = 5 min. Within the 5-min period, a dynamic mitochondrial network would usually spread out or connect with neighbor mitochondria, In WT neurons, mitochondria spread out and increased the area of photoswitched mitochondria by about 40% within the 5-min period (Fig. 4g ). However in KO neurons this increase was only ~10% (Fig. 4h ). These data support our hypothesis that Fmr1-KO neurons exhibit reduced mitochondrial fusion.
A number of proteins are involved in mitochondrial fusion and fission 17 
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mitochondrial outer membranes, and while optic atrophy 1 (OPA1) acts in inner membrane. Dynamin-related protein 1 (DRP1) and fission 1 protein (FIS1) mediate mitochondrial fission ( Fig. 4i ).
Mfn2, Mfn1 and Drp1 mRNA were downregulated in KO DsRed + adult immature neurons (Supplementary Table 1 , Supplementary  Fig. 10d ). Additionally, MFN1 and MFN2 were significantly lower Opa1, WT = 0.04076 ± 0.01003, n = 7 mice; KO = 0.01826 ± 0.006013, n = 7 mice, t(12) = 1.924, P = 0.0784. Mfn1, WT = 0.06412 ± 0.003417, n = 7 mice; KO = 0.03351 ± 0.004111, n = 7 mice, t(12) = 5.727, P < 0.0001; Mfn2, WT = 0.08783 ± 0.01551, n = 7 mice; KO = 0.03231 ± 0.007524, n = 7 mice, t(12) = 3.220, P = 0.0072; Drp1, WT = 0.03046 ± 0.002363, n = 7 mice; KO = 0.03891 ± 0.004793, n = 7 mice, t(12) = 1.582, P = 0.1397; Fis1, WT = 0.02480 ± 0.002401, n = 7 mice; KO = 0.02020 ± 0.002939, n = 7 mice, t(12) = 1.213, P = 0.2483). *P < 0.05, **P < 0.01, ***P < 0.001. All error bars reflect mean ± s.e.m. To test the hypothesis that mitochondrial fusion deficits in FMRP-deleted immature neurons contribute to impaired maturation, we treated Fmr1-KO and WT neurons with M1, a cell-permeable phenylhydrazone that promotes mitochondrial fusion and restores mitochondrial tubular network in neuronal cells 32 (Fig. 5a ). M1 treatment restored aspect ratio of mitochondria in the KO neurons to the levels of the WT neurons (Fig. 5b,c) . Additionally, M1 treatment partially rescued dendritic maturation deficits of KO neurons, without significant effect on WT neurons ( Fig. 5d -f) or significant impact on protein levels of MFN1 and MFN2 ( Supplementary  Figs. 13, 14 and 24 ). Furthermore, exogenous MFN2 rescued both fragmented mitochondrial ( Fig. 5g -i) and dendritic ( Fig. 5j -l) morphogenesis in Fmr1-KO neurons, without a significant effect on WT neurons. Exogenous MFN1 exhibited a similar effect to that of MFN2 ( Supplementary Fig. 15 ). Together, these data demonstrate that restoration of mitochondrial fusion significantly ameliorated impaired dendritic maturation induced by FMRP deficiency.
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Reduced HTT levels in FMRP-deficient developing neurons contribute to mitochondrial dysfunction and neuronal maturation deficits. We next investigated how FMRP regulates mitochondrial fusion. There were 40 common FMRP targets identified in mouse forebrain 3 , human HEK293 cells 11 and mouse hippocampus 10 ( Supplementary Table 4 ). However, none of these 40 FMRP targets was among the 519 differentially expressed genes we found in Fmr1-KO immature neurons ( Fig. 3 ), suggesting that these 519 differentially expressed genes might be indirectly regulated by FMRP. We then used the BioGRID database (Supplementary Table 5 ) to identify genes with known one-degree physical interactions with the 519 differentially expressed genes and discovered that 18 were among the 40 FMRP targets ( Supplementary Fig. 16 , Supplementary Table 6 ). We also used BioGRID to search for genes that had first-degree interaction with the seven mitochondria-related genes (defined by PATHER, Supplementary Table 3b ) among the 519 differentially expressed genes. Surprisingly, only Htt was found to be among the 40 FMRP targets, suggesting that Htt is the most likely FMRP target involved in FMRP regulation of mitochondria in immature neurons ( Supplementary Fig. 16 ). Other than genome-wide studies 3,10,11 , a direct interaction between FMRP and Htt mRNA has not been validated. We performed RNA-binding-protein immunoprecipitation and identification of coprecipitated RNA (RNA-IP), using an FMRP antibody, coupled with real-time PCR analysis. The FMRP RNA-IP sample was highly enriched for Htt but not Mfn1, Mfn2 or Fis1 mRNAs compared with Gapdh control mRNAs ( Supplementary  Fig. 17a ). We next assessed the levels of HTT protein in immature neurons and found that the tdT + neurons in the DG of cKO;Cre;tdT mice exhibited significantly reduced HTT immunostaining intensity compared with those in control mice (Fig. 6a,b ). Additionally, Htt mRNA levels were significantly lower in Fmr1-KO DG tissue of 3-week-old mice ( Fig. 6c) , with a high proportion of DCX + cells 24 . Furthermore, Htt mRNA levels were significantly lower in Fmr1-KO primary hippocampal neurons, compared with controls ( Fig. 6d ). To determine how FMRP deficiency affects Htt mRNA levels, we determined the stability of Htt mRNA in KO and WT hippocampal neurons treated with transcriptional inhibitor actinomycin D. We found that Htt mRNA had a reduced half-life (T 1/2 ) in Fmr1-KO neurons (3.86 h) compared with WT neurons (4.18 h; Supplementary Fig. 17b ). Therefore, FMRP directly binds Htt mRNA and maintains the stability of Htt mRNAs, and FMRP deficiency leads to reduced Htt mRNA and HTT protein levels.
Although pathological HTT signaling is known to induce mitochondrial changes, including loss of membrane potential and 
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abnormal mitochondrial dynamics 33 , nearly all functional studies of HTT have been performed in the context of the CAG-repeatcontaining HTT gene. The impact of HTT deficiency on either neuronal or mitochondria functions remains largely unexplored. We infected hippocampal neurons with a lentivirus expressing shRNA against Htt (shHtt) and GFP. We found that shHtt-infected neurons showed a significant reduction in both mRNA and protein levels of HTT ( Fig. 6e,f, Supplementary Figs. 18 and 25 ), as well as mRNA and protein levels of MFN2 and OPA1 but not Fis1 and Drp1 mRNA levels compared with shNC infected neurons, (Fig. 6g-l and Supplementary Fig. 18 ). Additionally, hippocampal neurons with HTT knockdown (shHtt) exhibited significantly reduced dendritic complexity, dendritic length and number of dendritic nodes ( Fig. 6m-p) . These results indicate that HTT deficiency in immature neurons leads to reduced mitochondrial fusion gene expression and impaired dendritic maturation, which phenocopies the deficits observed in FMRP-deficient developing neurons. 
CRISPR/dCas9-targeted activation of endogenous
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neurons, we sought to test whether increasing the expression levels of HTT may rescue mitochondrial fusion and dendritic maturation deficits of FMRP-deficient neurons. Because HTT protein is large (∼348 kDa), with 9,429 nucleotide protein-coding sequences for human and 9,663 for mouse, it is at the limit of the maximal capacity of lentiviral packaging. We were also concerned that overexpression of full-length HTT may lead to off-target effects. We therefore designed a guide RNA (sgRNA)-guided sequence-specific transcription activation system that utilized a fusion protein of inactive Cas9 (dCas9) and transcriptional activation domain VP64 (dCas9-VP64) together with a synergistic activation mediator (SAM, MS2-p65-HSF1) that enhances the effect of transcription activation 34 . We designed ten sgRNAs targeting various sequences in the proximal promoter, between -400 bp and -7 bp relative to transcription start site (TSS) of the mouse Htt gene. The sgRNA candidates #2, #3, #6 and #10 exhibited the strongest effects in elevating the endogenous Htt mRNA levels in transfected Neuro2A cells (Fig. 7a ). Among them, sgRNA #6 and #10 significantly enhanced the levels of endogenous HTT protein levels in transfected hippocampal neurons ( Fig. 7b and Supplementary Fig 19) . We then transfected Fmr1-KO or WT primary hippocampal neurons with either sgRNA #6 or #10 together with dCas9-V164, SAM, mitoDsRed, and GFP on DIV 4 and analyzed the mitochondrial morphology and oxidative stress level of the neurons on DIV7 (Fig. 7c-f ). Htt gene activation by sgRNA #6 (HTT #6) led to a significant increase in HTT protein levels in both WT and KO neurons compared with those under control sgRNA conditions, and more importantly restored the HTT levels in KO neurons to the WT level (Fig. 7d ). Htt gene activation increased the aspect ratio of mitochondria ( Fig. 7e) and reduced the nitrotyrosine level (Fig. 7f) in Fmr1-KO neurons without a significant effect on WT neurons. Additionally, Htt gene activation rescued dendritic complexity of KO neurons without a significant effect on WT neurons (Fig. 8a-c) . Activation of HTT using sgRNA #10 showed similar effects as sgRNA #6 (Figs. 7c-f, 8a-c) . Therefore, these data suggest that HTT, a target of FMRP in immature neurons, is central to FMRP regulation of mitochondrial function and neuronal maturation.
M1 treatment rescues behavioral deficits of Fmr1-KO mice and mice with HTT knockdown in the hippocampus. Because M1 treatment rescued both mitochondrial and neuronal morphology in
Fmr1-KO neurons (Fig. 4) , we next investigated whether M1 could rescue the behavioral deficits in Fmr1-KO mice (Fig. 8d ). Consistent with literature 26, 35, 36 , vehicle-treated Fmr1-KO mice exhibited hyperactivity in an open-field test (Fig. 8e ), without significant changes in anxiety-related center-field preference ( Supplementary Fig. 20a ), and impaired spatial working memory in a novel location test (Fig. 8f , Supplementary Fig. 20c-e ), impaired interaction with a novel mouse (social novelty, Fig. 8g, Supplementary Fig. 21a-e ). M1 treatment rescues these deficits observed in Fmr1-KO mice (Fig. 8e-g) .
We next acutely knocked down HTT in adult DG of WT mice using lentivirus expressing shHtt followed by behavioral assessments at 21 days later (Fig. 8h ). We found that mice with HTT knocked down in the DG exhibited no change in open-field activities ( Fig. 8i , Supplementary Fig. 20a ), but exhibited impaired spatial working memory ( Fig. 8j, Supplementary Fig. 20c,f,g) and interaction with a novel mouse ( Fig. 8k, Supplementary Fig. 21f-i) . Intriguingly, these deficits were rescued by M1 treatment (Fig. 8j,k, Supplementary Fig.  21f-i) . Therefore, behavioral deficits in mice lacking either FMRP or HTT could be rescued by a compound that promotes mitochondrial fusion, supporting the converging deficits in mitochondrial functions of these two disease genes ( Supplementary Fig. 22 ).
Discussion
In this study, we show that FMRP deficiency in immature neurons leads to impaired mitochondrial fusion and that enhancing mitochondrial fusion restores neuronal maturation in Fmr1-KO neurons. Our work provides the first direct evidence that links FMRP deficiency and mitochondrial dysfunction. Our surprising discovery of HTT as a key mediator of FMRP regulation of mitochondria unveils a previously unknown cross-talk between these two human disease genes.
Interrogating cell-type-specific and developmental-stagespecific roles of FMRP is critical for understanding the disease mechanism and developing effective treatment for FXS. We have 
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previously shown that deletion of FMRP in adult NSCs leads to a reduced number and impaired dendritic complexity of new hippocampal neurons 9, 24 . However, such deficits could be a consequence of either reduced neuronal differentiation of NSCs or impaired maturation of neurons 24, 26 . Here we show that selective deletion of FMRP from DCX-expressing immature neurons had no significant effect on neuroblast proliferation, in contrast to its role in regulating NSC proliferation 26 , but led to a reduced number of new mature neurons at all time points. Additionally, these DG neurons had not only impaired morphological maturation but reduced frequency of mEPSC, suggesting that impaired excitatory synaptic input and deficient integration into the neural circuitry 37, 38 . Therefore, our present study demonstrates that FMRP has distinct roles in immature neurons, independent of its roles in NSCs 24, 26 , and FMRP deficiency significantly affects the final stage of maturation of new neurons.
Several studies have investigated mitochondrial function in fragile X-associated tremor/ataxia syndrome (FXTAS), which is caused by premutation expansions of the CGG repeat in the 5′ untranslated region of the FMR1 gene, leading to overexpression of mutant CGG-repeat-containing FMR1 mRNAs. Both hippocampal neurons isolated from premutation mouse models 39 and fibroblasts from patients with FXTAS 40 showed abnormal mitochondrial numbers and functions. However, patients with FXTAS retain FMRP protein expression at various levels, and their pathology is probably due to the presence of mutant FMR1 mRNAs rather than the absence of FMRP protein. Our current study reports for the first time the 20 Articles NATuRE NEuROsciENcE contribution of mitochondrial dysfunction in FXS. Mitochondria are dynamic organelles continuously remodeled through the balance between fusion and fission events, which are mediated by both the fusion machinery including MFN1, MFN2, and OPA1 and the fission machinery, including FIS1 and DRP1 41 . Mice deficient in either MFN1 or MFN2 die midgestation, and embryonic fibroblasts lacking MFN1 or MFN2 display fragmented mitochondria 42 . MFN2 is critical in many cell types 43 . Specific deletion of MFN2 leads to reduced mitochondrial transport, impaired respiratory chain function and aberrant mitochondrial morphology, leading to increased oxidative stress and neuronal death [44] [45] [46] . MFN2 knockdown in human induced pluripotent stem cells results in defective neurogenesis and synapse formation, whereas MFN2 overexpression promotes maturation of human neurons 47 . Therefore, mitochondrial fusion is important for neuronal maturation. Our data suggest that MFNs and mitochondria might be potential treatment targets for FXS. Abnormal expansion of a CAG repeat located in exon 1 of the human HTT gene leads to Huntington's disease, a neurodegenerative disorder 33 . Studies investigating the toxic effects of mutant HTT in cell culture or animal models have revealed mitochondrial changes including a loss of membrane potential, abnormal mitochondrial dynamics and increased oxidative stress 33 . The tissues and cells of patients with Huntington's disease have increased mitochondrial fragmentation due to decreased levels of MFN1, MFN2 and OPA1 levels and increased DRP1 and FIS1 levels 48 . However, most of these studies were done in the context of the CAG-repeatcontaining HTT gene. The exact function of HTT protein itself remains unclear 33 . HTT is widely expressed and is thought to be involved in diverse cellular activities such as regulation of transcription, transporting materials, binding proteins and other structures, endocytosis and autophagy 33 . The HTT/Htt gene locus in both human and mouse is large, spanning 180 kb and consisting of 67 exons; therefore, understanding the normal biological functions of non-mutant HTT protein remains a challenge, and activation and restoration of HTT protein with high efficiency has not been achieved 49 . To restore HTT levels in Fmr1-KO neurons without confound of exogenous HTT overexpression, we used a Htt genespecific guide RNAs to direct a dCas9-VP64 fusion protein together with SAM amplification system 34 to the endogenous Htt gene promoter. We demonstrate that this is an effective method for studying functions of HTT or other large proteins in neurons or other cell types. Htt mRNA has been identified as a target of FMRP 3,10,11,50 ; however, the functional significance of FMRP regulation of Htt remains unexplored. We show that HTT levels directly impact the levels of Mfn2, a gene downregulated in FMRP-deficient neurons. Both HTT and FMRP are widely expressed with potentially many interactors and targets. Both Fmr1-KO mice and mice with hippocampal HTT knockdown exhibited spatial working memory and social novelty deficits. The fact that treatment with a mitochondrial fusion promoting compound rescued these deficits further support that mitochondrial fusion might be one of the convergent mechanisms underlying the functions of FMRP and HTT. On the other hand, it is possible that FMRP and HTT may regulate certain mitochondrial functions independently of each other. In fact, we found that acute knockdown of Htt led to decreased Opa1 mRNA level but had no significant impact on Mfn1 (Fig. 6l,m) , whereas Fmr1-KO neurons had reduced levels of both Mfn1 and Mfn2 but not Opa1 (Fig. 4k ). HTT knockdown in the DG did not lead to hyperactivity, as seen in Fmr1-KO mice, which could be due to either differential functions of these two proteins or due to restricted effects from regional knockdown of HTT. Nevertheless, our study has elucidated a novel role of HTT in FMRP regulation of mitochondrial function and dendritic maturation. Further studies on the cross-talk between these two proteins will shed light on our understanding of the pathogenesis of both Huntington's disease and FXS.
Accession codes. Transcriptome data for this project are available at GEO accession number GSE117111.
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Methods
Mice. We performed all procedures involving live mice in accordance with the NIH Guide for the Care and Use of Laboratory Animals and the protocols approved by the University of Wisconsin-Madison Animal Care and Use Committee. We generated the inducible conditional mutant mice (Fmr1 loxP/y ; Tg(Dcx-cre/ERT2);Gt(ROSA)26Sor tm14(tdTomato)Hze , simplified as cKO;Cre;tdT) by crossing Fmr1-floxed (Fmr1 loxP/+ ) mice with Tg(Dcx-cre/ERT2) transgenic driver (Dcx-Cre ERT2 ; MMRRC, provided by U. Mueller, Scripps Institute, San Diego, CA) mice and Gt(ROSA)26Sor tm14(tdTomato)Hze reporter (tdT) mice. The Fmr1 loxP/+ mice have been bred onto a C57BL/6J genetic background 51 . The Dcx-Cre ERT2 mice are 100% C57BL/6J background (stock # 032780-MU donated by U. Muller). The tdT mice (C57B/L6J background) were from Jackson Laboratory (stock # 007914). Mice were then crossed with the Dcx-Cre ERT2 mice. The inducible Fmr1 conditional knockout was generated as follows: Dcx-Cre ERT2 , tdT male mice were crossed with heterozygote female Fmr1 loxP/+ mice. The male offspring were either cKO;Cre;tdT or control (Ctrl, or Ctrl;Cre;tdT) mice to be used in experiments. We also generated the Fmr1 −/y /Dcx-DsRed mice and Fmr1 +/y /Dcx-DsRed mice. The Fmr1-KO mice bred on the C57B/L6 genetic background was as described previously 29 . The Dcx-DsRed mice 52 (Jackson Laboratory stock #009655) have been backcrossed to a C57BL/6J background. Those male mice were crossed with heterozygote female Fmr1 −/+ mice. The male offspring were used in experiments. Mice were genotyped as previously described 51, 53, 54 . To induce recombination, mice (6 weeks old) received tamoxifen (Sigma-Aldrich) daily for 3 d (160 mg kg-1 intraperitoneally, 40 mg ml -1 in 10% ethanol mixed with sunflower oil, Sigma-Aldrich). M1 (20 mg kg −1 ) or vehicle was given to 2-to 4-month-old mice through intraperitoneal injection 24 h before each behavioral test.
Data collection timing and blinding. Data collection was carried out for a predetermined period of time, as dictated by literature or core facility-based standards, and no exclusion criteria were applied. For drug treatment, animals were randomly assigned to treatment arms with approximately equivalent numbers in each group. All cell counting and behavioral analyses were performed by experimenters who were blind to the identity and treatments of the samples.
Tissue preparation and immunohistochemistry. Histological analysis of mouse brains were performed as described previously with modifications 29, 53 . At 3, 7, 14, 28 or 56 d after the last TAM injection, mice were euthanized by intraperitoneal injection of sodium pentobarbital and then transcardially perfused with saline, followed by 4% PFA. Brains were dissected, post-fixed overnight in 4% PFA, and then equilibrated in 30% sucrose. 40-µm brain sections were generated using a sliding microtone and stored in a -20 o C freezer as floating sections in 96-well plates filled with cryoprotectant solution (glycerol, ethylene glycol, and 0.1 M phosphate buffer, pH 7.4, 1:1:2 by volume). Immunohistology was performed as published previously 29, 53, 55 . The tissue sections were preblocked with TBS++ (TBS containing 3% goat or donkey serum and 0.2% Triton X-100) for 1 h at room temperature, followed by incubation with primary antibodies diluted in TBS++ overnight in 4°C. After three washes, secondary antibodies were incubated 1 h at room temperature. All sections were counterstained with a nuclear counter stain, DAPI (4' ,6-diamidine-2'-phenylindole dihydrochloride, 1:2,000, Roche Applied Science, Indianapolis, IN).
The primary antibodies used were: chicken anti-GFP (Invitrogen, Carlsbad, CA, #A10262), rat anti-Ki67 (1:500, eBioscience, 14-5698, San Diego, CA, USA), rabbit anti-GFAP (1:2000, DAKO, #Z0334, Carpinteria, CA, USA), chicken anti-Nestin (1:500, Aves Labs, #NES0407, Tigard, OR, USA), rabbit anti-Doublecortin (1:500, Cell Signaling Technology, #4604 S, Beverly, MA, USA), rabbit anti-cleaved caspase-3 (1:500, Cell Signaling, #9661, Danvers, MA, USA), mouse anti-NeuN (1:500, Millipore, MAB377, Billerica, MA, USA), rabbit anti-S100β (1:1,000, Dako, Z0334, Carpinteria, CA, USA), mouse anti-FMRP (1:500, Millipore, MAB2160), mouse anti-Nitrotyrosine (39B6) (1:500, Santa Cruz Biotechnology, sc-32757, Texas, DA, USA), mouse anti-OPA1 (1:1,000, Abcam, ab157457, Cambridge, MA) mouse anti-MFN1 (1:1,000, Abcam, ab57602, Cambridge, MA), rabbit MFN2 (1:500, Proteintech, 12186-1-AP, Rosemont, IL), rabbit anti-DRP1 (1:1,000, Abcam, ab184247, Cambridge, MA) and mouse anti-Huntingtin (3E10) (1:500, Santa Cruz Biotechnology, sc-47757, Texas, DA, USA).
Fluorescent secondary antibodies used by 1:500 dilution: goat anti-chicken 488 (A11039, Invitrogen), goat anti-mouse 568 (A11004, Invitrogen), goat anti-rabbit 647 (A21245, Invitrogen), donkey anti-goat 568 (A11057, Invitrogen), donkey anti-rabbit 647 (A31573, Invitrogen), goat anti-mouse 647 (A21235, Invitrogen), goat anti-rabbit 568 (A11011, Invitrogen), and donkey anti mouse 647 (A31571, Invitrogen). After staining, sections were mounted and maintained at 4 o C in the dark until analysis.
In vivo cell quantification and fate mapping. Quantification and fate mapping of tdT + cells in the DG was performed as previously described 24 . For quantification of tdT + SGZ cells, 1 in 12 serial sections starting at the beginning of hippocampus (relative to bregma, −1.5 mm) to the end of hippocampus (relative to bregma, −3.5 mm) were used. DG volume and the total tdT + cells in the SGZ, inner half side of granule layer, outer half side of granule layer were analyzed using unbiased stereology (StereoInvestigator, MBF Biosciences, Inc) as described elsewhere 29, 55 .
The signal intensity of FMRP, HTT or nitrotyrosine in tdT + cells in the DG of each animal was quantified using Image J software as previously described 27 . The z-stack images (2 μm interval) were acquired using a Nikon A1 confocal microscope. At least ten individual tdT + cells were randomly selected from DG of the brain sections in each animal and the fluorescent intensity of FMRP, HTT or nitrotyrosine was measured after subtracting background pixel intensity in the same image using Image J software (NIH). The average intensity from each animal (at least 10 cells) was count as n = 1 for statistical analysis. Samples from three to four individual animals, each from a different litter, per experimental condition were analyzed (n = 3 or 4).
The signal intensity of FMRP and GFP in GFP + cells in the DG of retrovirus injected mice was quantified using Image J software. The z-stack images (2 μm interval) were acquired using Nikon A1 confocal microscope. A line was drawn through the soma of each GFP + cell and the intensity of GFP and FMRP was measured along that line. The intensity of FMRP signal was then plotted alongside background FMRP signal intensity and GFP signal intensity.
In vivo fate mapping of tdT + cells was performed as previously described 53 . Briefly, over 100 tdT + cells in the DG were randomly selected, and their phenotypes (double labeling with NeuN, S100β, Tbr2, Nestin, GFAP, DCX or Ki67, caspase3) were determined using a Nikon A1 laser scanning confocal microscope. Data were presented as the percentage of tdT + cells.
Plasmids and reagents.
Retro-pDcx-Cre and Retro-Flip-GFP were cloned using Retro-CAG-red fluorescent protein (RFP) 56 as the backbone. Briefly, CAG and RFP coding sequence were replaced with coding sequences of pDcx-Cre or DIO(GFP). Retroviral vector (Retro-SYN-GFPCre) was subcloned from RV-SYN-GTRgp (a general gift from H.v.P. (NIH), N.S. (Cleveland Clinic), and F. H. Gage (The Salk Institute) and was described in their publication 57 by adding the GFPCre fragment after syn promotor. Retro-CAG-IRES-mitoDsRed was a general gift from D. Lie and described in his publication 16 . shFmr1-mCherry and shNC-mCherry were cloned from our published retroviral vectors expressing shFmr1 and GFP 9 .
Synapsin-GFP and synapsin-mitoDsRed were gifts from C. Chang (University of Wisconsin-Madison) and described in his publication 58 . All the sequences inserted into the backbones were confirmed by sequencing. Mfn1 and Mfn2 were a gift from D. Chan 42 (Addgene plasmid # 23212; # 23213). For in vivo tests, mitochondrial fusion promoting compound M1 (Sigma-Aldrich SML0629) was made in a stock concentration of 50 mg/ml in dimethyl sulfoxide (DMSO) and then diluted to 5 mg/ml in sunflower oil. For in vitro tests, M1 (10 μg/ml in 0.1% DMSO) was administrated 24 h before fixation of neurons for analysis.
Lenti-shHtt and shNC were cloned using lentivirus-shNC vector as a backbone 59 and the U6 or H1-shRNA cassettes were also cloned intro the backbone through HpaI/ClaI restriction sites. The efficiency and specificity of shRNA knockdown were determined by transfecting into Neuro2A using Lipofectamine 2000 (Invitrogen, #11668-027), and analyzed at 60 h post-transfection by qPCR.
Lenti-dCAS-VP64 (Addgene #61425), lenti-MS2-P65-HSF1 (Addgene #61426) and lenti sgRNA (Addgene #61427) (SAM system) were gifts from F. Zhang 34 . Ten sgRNAs targeting the proximal promoter of mouse Htt gene (HTT#1-10), between -400 bp and -7 bp relative to the TSS, were designed in benchling based on published scoring methods 60, 61 and cloned to the lentiviral sgRNA vector (Addgene #61427). The efficiency of activation of Htt were determined by transfecting the SAM plasmids into Neuro2A using Lipofectamine and analyzed at 60 h posttransfection by qPCR.
Production of lentivirus and retrovirus.
Lentivirus production was performed as described previously 55, 62, 63 . Retrovirus production was performed as described in our previous publications 55, 59, 64 . Briefly, lentiviral DNA was cotransfected with packaging plasmids pMDL, REV and pCMV-Vsvg into HEK293T cells using calcium phosphate method. Retroviral DNA was cotransfected with packaging plasmids pCMV-gag-pol and pCMV-Vsvg into HEK293T cells using calcium phosphate method. The viral transfer vector DNA and packaging plasmid DNA were transfected into 5 × 15 cm dishes of cultured HEK293T cells using the calcium phosphate method. The medium containing lentivirus was collected at 36 and 60 h post-transfection, pooled, filtered through a 0.2-µm filter, and concentrated using an ultracentrifuge at 19 k r.p.m. for 2 h at 4 °C using a SW27 rotor (Beckman). The virus was washed once and then resuspended in 100 µl PBS. We routinely obtained 1 × 10 9 infectious viral particles /ml for lentivirus and 1 × 10 8 infectious viral particles/ml for retrovirus.
In vivo retroviral grafting and morphological analysis of targeted neurons.
In vivo virus grafting was performed as described 24, 59, 64 . Briefly, 6-week-old male mice were anesthetized with isofluorane and placed in a stereotactic instrument (DAVID KOPF Instruments, Tujunga, CA). Microinjections were performed using custom-made injection 33-gauge needles (Hamilton, #776206, Reno, NV, USA) connected to a 10 µL syringe (Hamilton, #87930). Virus (1 µl with titer greater than 1 × 10 8 /ml) was mixed and then stereotaxically injected into the dentate gyrus using the following coordinates relative to bregma, caudal: +2.0 mm; lateral: +/−1.6 mm; ventral: −2.0 mm. 4 weeks post viral grafting, mice were perfused for differential analysis. Mice were deeply anesthetized with pentobarbital and perfused with saline followed by 4% PFA. Morphological analyses of retroviral Novel location test. The experimental procedure was developed by the core facility of Waisman Center at UW-Madison as previously described 26, 27 . Briefly, mice were handled for approximately 5 min per day for a maximum of 5 days prior to the experiment. All procedures were conducted during the light cycle of the animal between 9 a.m. and 6 p.m. Before the trial session, mice were brought into testing room and were allowed to acclimate for at least 30 min. Testing consisted of five 6-min trials, with a 3-min intertrial interval between each trial. During the intertrial interval, the mouse was placed in a holding cage, which remained inside the testing room. In the first trial (pre-exposure), each mouse was placed individually into the center of the otherwise empty open arena (38.5 cm long × 38.5 cm wide, and 25.5 cm high walls) for 6 min. For the next three trials (sample trials 1-3), two identical objects were placed equidistantly from the arena wall in the corners against the wall with the colored decal. Objects were taped to the floor of the arena. Then, each mouse was placed individually into the center of the arena and allowed to explore for 6 min. At the end of the trial, the mouse was removed and returned to the home cages for 3 min. In the last trial (test), one of the objects was moved to a novel location, and the mouse was allowed to explore the objects for 6 min, and the total time spent exploring each object was measured. During the test phase, exploration time was defined as any investigative behavior (that is, head orientation, climbing on, sniffing occurring within <1.0 cm) or other motivated direct contact occurring with each object. To control for possible odor cues, objects were cleaned with 70% ethanol solution at the end of each trial and the floor of the arena wiped down to eliminate possible scent/trail markers. During the test phase, two objects were wiped down prior to testing so that the objects would all have the same odor. Based on a study 75 , the discrimination index was calculated as the percentage of time spent investigating the object in the new location minus the percentage of time spent investigating the object in the old location: discrimination index = (novel location exploration time/total exploration time × 100) -(old location exploration time/total exploration time × 100). A higher discrimination index is considered to reflect greater memory retention for the novel location object. All experiments were videotaped and scored by scientists who were blinded to experimental conditions to ensure accuracy.
Three-chamber sociability tests. Three-chamber social behavior test was carried out as previously described 37, 76 . The social behavior testing apparatus was a three-chambered box, with the dimensions of each chamber being 40 cm in length, 22 cm in width, and 23 cm in height. Dividing walls were made of clear Plexiglas containing small circular doors (7 cm in diameter) allowing access into each chamber. The procedure involved three phases: habituation, tests of 
Transfection and in vitro analysis of primary hippocampal neurons.
Hippocampal neurons were isolated and transfected as described previously 59 . Briefly, hippocampal neurons from KO or WT P0-1 neonate mice were grown as dispersed mixed cell cultures. The hippocampal neurons were transfected with synapsin-GFP or synapsin-mitoDsRed using the calcium phosphate precipitation on DIV 4 as they were undergoing dendritic and axonal morphogenesis during this time. At 72 h after transfection (DIV 7), transfected neurons were fixed with 4% paraformaldehyde, washed with Dulbecco's phosphate-buffered saline, and coverslipped in DAVCO-PVA. Dendritic morphological analysis was carried out with an Olympus BX51 microscope with 20× lens, a motorized stage and digital camera. Dendritic traces were performed in real-time using Neurolucida software (MicroBrightField). Approximately 30 neurons were analyzed for each group in each experiment. For mitochondrial morphology analysis, mitoDsRed-positive neurons were imaged using an AxioImagerZ2 ApoTome confocal microscope (Plan-APOCHOROMAT, 20× , numerical aperture = 0.8; Zeiss) or A1RSi confocal microscope system (Nikon) with a 60× oil objective. The aspect ratio of mitochondria in neurites was analyzed using ImageJ (RRID: SCR_003070) with mitochondrial morphology plug-in as previously described 67 .
Photoswitched live imaging of mitochondria. The fluorescent protein mEos3.2 (ref. 73 ) was cloned into an expression vector containing an EF1 alpha promoter and a mitochondrial import sequence from subunit VIII of human cytochrome c oxidase (pEF mito-mEos3.2/pJDV0021). The primary hippocampal neurons were transfected with pEF mito-mEos3.2 using the calcium phosphate precipitation on DIV 4. At 72 h after transfection (DIV 7), transfected neurons were imaged with an Olympus FV1000 spectral based BX61WI (water immersion) upright laser scanning confocal microscope. Three images were acquired. One image before photoswitching, the second image immediately after photoswitching a small area of dendritic mitochondria (T = 0), and a third image five minutes later (T = 5 min). The photoactivated (red) channel was thresholded to mitochondrial structures, and total 'red' area was calculated. Data are presented as total photoswitched area at T = 0 paired with total photoswitched area at T = 5 min. WT mitochondria move and fuse to other nearby mitochondria, spreading the red signal over a large area, whereas mitochondria deficient in fusion do not spread the red (photoswitched) signal to nearby mitochondria.
Measurement of mitochondrial membrane potential. The mitochondrial membrane potential in neurons on DIV 7 was determined by JC-10 Mitochondrial Membrane Potential Assay Kit (Abcam), following the manufacturer's protocol. Briefly, neurons were stained with JC-10 solution for 30 min at 37 °C. Neurons incubated with mitochondrial uncoupler FCCP (carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, 10 μM, Sigma-Aldrich) for 30 min were used as a negative control. After adding buffer B, neurons were imaged using an A1RSi confocal microscope system (Nikon) with a 20× objective. The mitochondrial membrane potential was assessed by the quantifying the ratio of the intensity of red fluorescence (emission wavelength 590 nm) to green fluorescence (emission wavelength 520 nm).
Analysis of HTT protein level in primary hippocampal neurons. DIV7 WT hippocampus neurons were infected with lenti-shHtt or -shNC and the cells were fixed using 4% PFA 48 h postinfection. DIV7 Fmr1-KO or WT hippocampus neurons were fixed using 4% PFA and analyzed. The signal intensity of HTT in GFP + cells in the infected group or DCX + cells in untreated group was quantified using Image J software. The images were acquired using Nikon A1 confocal microscope with a 20× objective. At least 30 individual GFP + or DCX + cells were randomly selected from each group and the fluorescent intensity of HTT was measured after subtracting background pixel intensity in the same image using Image J software (NIH).
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